GMP of Godavari Biorefineries IPO Falls Sharply: Key Details Before Listing

The IPO of Godavari Biorefineries, one of India’s leading producers of ethanol and alcohol-based chemicals, closed recently and is set to list on October 30. While the IPO was moderately oversubscribed, a significant drop in the grey market premium (GMP) indicates a less enthusiastic outlook from investors. Let’s dive into the essential details of the IPO, from allotment to GMP trends and listing expectations.

IPO Allotment and Listing Details

The IPO, which raised Rs 554.75 crore, concluded its allotment process. Investors can now check their allotment status on the websites of BSE, NSE, and registrar Link Intime India. The approved shares will be credited to investors’ demat accounts by October 29, and refunds will be initiated on the same date for those who didn’t secure an allotment. As we approach the listing on October 30, the recent GMP trends give insights into the expected performance on listing day.

Decline in GMP: What It Indicates for Listing Day

The GMP for Godavari Biorefineries has taken a steep hit, dropping to Rs 5 in the grey market. This suggests only a modest listing gain of about 1%, a stark contrast from the Rs 25 premium it commanded when the issue opened. The muted response in the grey market indicates that investor sentiment is cautious, likely due to market conditions or the valuation of the IPO itself.

• Initial GMP at Issue Open: Rs 25 per share
• Current GMP: Rs 5 per share
• Expected Listing Premium: Approximately 1%

IPO Subscription Overview: Moderate Demand Across Categories

Godavari Biorefineries’ IPO saw an overall subscription rate of 1.83 times, reflecting moderate investor interest. Among the various categories, Qualified Institutional Buyers (QIBs) showed the highest interest, while Non-Institutional Investors (NIIs) exhibited lower enthusiasm:

• QIB Subscription: 2.76 times
• Retail Individual Investors (RII) Subscription: 1.71 times
• NII Subscription: 0.90 times

The IPO, launched on October 23 and closed on October 25, had a price band of ₹334 to ₹352 per share.

Company Overview: A Diverse Portfolio in Bio-based Solutions

Headquartered in Mumbai, Godavari Biorefineries is a prominent player in bio-based chemicals and ethanol production in India. The company’s product portfolio includes:

• Bio-based Chemicals: Used in pharmaceuticals, flavors, and fragrances
• Ethanol: Vital for fuel and other industrial applications
• Sugar Production and Power Generation: Catering to diverse industries such as food, beverages, personal care, and cosmetics

Godavari Biorefineries’ unique position as a leading ethanol and alcohol-based chemicals producer has drawn interest, though the recent GMP decline suggests mixed investor confidence regarding its valuation and growth outlook.

Market Sentiment and Listing Outlook

Despite the solid fundamentals of Godavari Biorefineries, the significant GMP decline hints at a cautious listing day. With a final GMP of Rs 5, expectations point toward a modest listing premium. Investor sentiment in the grey market often reflects broader market trends and IPO demand, and the reduced GMP implies that the listing may align more closely with the IPO’s final offer price.

Conclusion: Moderate Listing Ahead for Godavari Biorefineries IPO

Godavari Biorefineries’ IPO listing on October 30 may result into limited gains due to a weakened GMP, indicating lukewarm market sentiment. While the company’s strong order book and diverse product offerings lend confidence to its business model, investors remain cautious about the immediate listing prospects.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.